What is the concentration of methotrexate solution for injection in mg/ml?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Methotrexate Concentration for Injection

The standard concentration of methotrexate solution for injection is 25 mg/ml. 1

Dosing for Ectopic Pregnancy

  • The standard dosing regimen for ectopic pregnancy is a single intramuscular injection of methotrexate at 50 mg/m² of body surface area 2, 1
  • This dose may be repeated as needed based on β-hCG level monitoring 1, 3
  • For high-risk cases, more intensive regimens may be required 1
  • The solution is typically administered as a single intramuscular injection, though some protocols use multiple doses 2, 3

Administration Considerations

  • Pre-treatment laboratory testing is required, including:
    • Complete blood count with differential and platelet counts 1
    • Liver enzyme levels 1
    • Renal function tests 1
  • Methotrexate is contraindicated in patients with:
    • Alcoholism or alcoholic liver disease 2
    • Immunodeficiency syndromes 2
    • Bone marrow hypoplasia, leukopenia, thrombocytopenia, or significant anemia 2
    • Hypersensitivity to methotrexate 2

Efficacy and Treatment Outcomes

  • Success rates for methotrexate treatment of ectopic pregnancy range from 71-95% 3, 4
  • Treatment failure is associated with:
    • β-hCG levels ≥4,000 mIU/mL 3
    • Ectopic mass >3.5 cm in diameter 4
    • Presence of fetal cardiac activity 3

Important Monitoring and Follow-up

  • Serial β-hCG monitoring is essential until levels are undetectable 1, 3
  • Patients should be monitored for potential rupture, which can occur up to 32 days after treatment 3, 4
  • Common side effects include nausea/vomiting (30%), gastritis, stomatitis (7%), and reversible alopecia (3%) 1

Alternative Dosing Approaches

  • Some studies have investigated lower doses (22-40 mg/m²) with similar success rates to the standard 50 mg/m² dose 5
  • Local injection directly into the ectopic sac (1 mg/kg) has shown higher success rates (91.5%) compared to intramuscular injection (71.4%), particularly when β-hCG levels are ≥2000 mIU/mL 6
  • Alternative dosing of 75 mg intramuscular (not based on body surface area) has shown 94.9% effectiveness in medical abortion studies 7

Warning Signs Requiring Immediate Attention

  • Severe abdominal pain, signs of hemodynamic instability, heavy vaginal bleeding, and shoulder pain require immediate medical attention 1, 4
  • Ruptured ectopic pregnancy must be considered in the differential diagnosis of patients who present with concerning symptoms after methotrexate therapy 2

Remember that methotrexate is administered in its concentrated form (25 mg/ml) and dosed according to body surface area calculations for most indications.

References

Guideline

Methotrexate Dosing for Molar Pregnancy Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ectopic Pregnancy Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Care for a Patient with Unruptured Ectopic Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Methotrexate for the treatment of unruptured tubal pregnancy: a prospective nonrandomized study.

JSLS : Journal of the Society of Laparoendoscopic Surgeons, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.